Syringe Dead Space and GLP-1 Dosing: The Small Error That Scales

Dead space is the fluid that stays behind in the needle and hub after you have pushed the plunger all the way down. It has been described as a dosing hazard in the insulin literature since at least 1982^[1], and it is quietly relevant to anyone drawing a GLP-1 from a compounded vial. The reason is arithmetic rather than chemistry: dead space removes approximately the same volume from every injection regardless of how much you drew. On a large draw that is a rounding error. On the very small draws that concentrated vials produce, it is a meaningful share of the dose.

Where the volume goes

When the plunger reaches the end of the barrel, a small volume remains in the hub where the needle meets the syringe, and inside the needle itself. That residual is dead space. It is a property of the device — its hub geometry and needle design — rather than of the drug or the technique, which is why work in other injection-based specialties has quantified how injector design changes the delivered dose for exactly this reason^[2].

The compounded-vial connection

This is where dead space stops being a technical footnote. Compounded GLP-1 vials are supplied at a range of concentrations, and a more concentrated vial means a smaller volume for the same prescribed milligrams. A patient told that a concentrated vial is “more convenient because you inject less” is being given a real benefit and an unmentioned cost: the smaller the draw, the larger the proportional effect of any fixed loss, and the harder it is to read the barrel accurately between graduation marks.

The figures above use one assumed residual volume to show the shape of the problem; actual dead space depends on the specific syringe and needle. The point is the trend, not the percentages: the curve gets steep exactly where concentrated vials put you.

What reduces it

• Low-dead-space syringes exist and are designed for this. They use a hub and plunger geometry that leaves less fluid behind. If your draws are small, this is the single most direct fix.
• A permanently attached needle usually beats a detachable one. A separate needle screwed onto a hub adds a junction where fluid can sit; an integrated needle typically retains less.
• Match the syringe to the draw. A syringe sized close to your actual volume makes graduations easier to read and reduces the proportion lost. Measuring 10 units in a 100-unit barrel is a reading problem as much as a dead-space problem.
• Do not try to compensate by drawing extra. Adding a bit "for the needle" replaces a known small loss with an unknown overdose, and it is not how the dose was prescribed. If the loss is material, the fix is a different syringe, prescribed by the clinician — not freelance arithmetic.
• Do not chase the last drop by pushing air through. Improvised techniques to clear the hub introduce their own risks and inconsistency. Consistency between injections matters more than recovering a fraction of a dose.

Keeping this in proportion

Dead space is a systematic, repeatable, modest loss. It is not the error that sends people to hospital — that is the scale confusion between units and milligrams, which a poison control case series documented producing multiples of the intended dose^[3]. Dead space is worth understanding precisely because it is the small error: consistent from week to week, largely invisible, and most relevant when someone switches syringe type or moves to a much more concentrated vial.

It also matters less than it would for a fast-acting drug. Weekly GLP-1 medications have half-lives measured in days — semaglutide's is approximately one week^[4] — so exposure is smoothed across the interval rather than depending on one sharp peak. A consistently slightly-low dose shows up as a slightly lower plateau, not as a dramatic weekly swing. That is a reason to raise it with your prescriber rather than to panic about a single injection.